Estrogen-regulated gene networks in human breast cancer cells: Involvement of E2F1 in the regulation of cell proliferation

Molecular Endocrinology

Volumn 21, Issue 9, 2007, Pages 2112-2123

  Stender, Joshua D ^a   Frasor, Jonna ^b   Komm, Barry ^c   Chang, Ken C N ^c   Kraus, W Lee ^d   Katzenellenbogen, Benita S ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c PFIZER INC   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; TRANSCRIPTION FACTOR E2F1;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RNA INTERFERENCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, ESTROGEN;

EID: 34548336347     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0474     Document Type: Article

References (58)

1. Jordan VC 2004 Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5:207-213
2. Katzenellenbogen BS, Frasor J 2004 Therapeutic targeting in the estrogen receptor hormonal pathway. Semin Oncol 31:28-38
3. Katzenellenbogen BS, Katzenellenbogen JA 2002 Defining the "S" in SERMs. Science 295:2380-2381
4. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA 2000 Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163-193; discussion 194-195
5. Osborne CK 1998 Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51:227-238
6. Hall JM, Couse JF, Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
7. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
8. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
9. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
10. Sanchez R, Nguyen D, Rocha W, White JH, Mader S 2002 Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24:244-254
11. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
12. Rosenfeld MG, Lunyak VV, Glass CK 2006 Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428
13. Kim MY, Hsiao SJ, Kraus WL 2001 A role for coactivators and histone acetylation in estrogen receptor α-mediated transcription initiation. EMBO J 20:6084-6094
14. Kraus WL, Wong J 2002 Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? Eur J Biochem 269:2275-2283
15. Cerillo G, Rees A, Manchanda N, Reilly C, Brogan I, White A, Needham M 1998 The oestrogen receptor regulates NFκB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 67:79-88
16. Lemon B, Tjian R 2000 Orchestrated response: a symphony of transcription factors for gene control. Genes Dev 14:2551-2569
17. Lonard DM, O'Malley BW 2006 The expanding cosmos of nuclear receptor coactivators. Cell 125:411-414
18. Schultz JR, Petz LN, Nardulli AM 2005 Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors α and β. J Biol Chem 280:347-354
19. Shang Y, Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
20. Foster JS, Henley DC, Ahamed S, Wimalasena J 2001 Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 12:320-327
21. Korach KS, Emmen JM, Walker VR, Hewitt SC, Yates M, Hall JM, Swope DL, Harrell JC, Couse JF 2003 Update on animal models developed for analyses of estrogen receptor biological activity. J Steroid Biochem Mol Biol 86:387-391
22. Nilsson S, Gustafsson JA 2002 Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37:1-28
23. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
24. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ER β in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145:3473-3486
25. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64:1522-1533
26. Soulez M, Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27:259-274
27. Levenson AS, Jordan VC 1994 Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem. Mol Biol 51:229-239
28. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC 2005 Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97:1746-1759
29. Licznar A, Caporali S, Lucas A, Weisz A, Vignon F, Lazennec G 2003 Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor. FEBS Lett 553:445-450
30. Lonning PE, Taylor PD, Anker G, Iddon J, Wie L, Jorgensen LM, Mella O, Howell A 2001 High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat 67:111-116
31. Song RX, Mor G, Naftolin F, McPherson RA, Song J, Zhang Z, Yue W, Wang J, Santen RJ 2001 Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17β-estradiol. J Natl Cancer Inst 93:1714-1723
32. Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC 2000 Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res 6:2028-2036
33. Gardner TS, di Bernardo D, Lorenz D, Collins JJ 2003 Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301:102-105
34. Lee TI, Rinaldi NJ, Robert F, Odom DT, Bar-Joseph Z, Gerber GK, Hannett NM, Harbison CT, Thompson CM, Simon I, Zeitlinger J, Jennings EG, Murray HL, Gordon DB, Ren B, Wyrick JJ, Tagne JB, Volkert TL, Fraenkel E, Gifford DK, Young RA 2002 Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298:799-804
35. Pilpel Y, Sudarsanam P, Church GM 2001 Identifying regulatory networks by combinatorial analysis of promoter elements. Nat Genet 29:153-159
36. Qian J, Lin J, Luscombe NM, Yu H, Gerstein M 2003 Prediction of regulatory networks: genome-wide identification of transcription factor targets from gene expression data. Bioinformatics 19:1917-1926
37. Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D, Friedman N 2003 Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 34:166-176
38. Lazennec G, Katzenellenbogen BS 1999 Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Mol Cell Endocrinol 149:93-105
39. Brown AMC, Jeltsch JM, Roberts M, Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344-6348
40. Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K 2000 WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun 275:108-114
41. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M 2006 Genomewide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297
42. Dyson N 1998 The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262
43. Ngwenya S, Safe S 2003 Cell context-dependent differences in the induction of E2F-1 gene expression by 17 β-estradiol in MCF-7 and ZR-75 cells. Endocrinology 144:1675-1685
44. Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG 2004 Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol 203:744-753
45. Wang W, Dong L, Saville B, Safe S 1999 Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13:1373-1387
46. Chang EC, Frasor J, Komm B, Katzenellenbogen BS 2006 Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147:4831-4842
47. Herman ME, Katzenellenbogen BS 1994 Alterations in transforming growth factor α and β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res 54:5867-5874
48. Herman ME, Katzenellenbogen BS 1996 Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from longterm exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol 59:121-134
49. Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H, Chalbos D 1998 FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol 12:973-985
50. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M 2006 A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20:2513-2526
51. Acevedo ML, Lee KC, Stender JD, Katzenellenbogen BS, Kraus WL 2004 Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Mol Cell 13:725-738
52. Ihmels J, Friedlander G, Bergmann S, Sarig O, Ziv Y, Barkai N 2002 Revealing modular organization in the yeast transcriptional network. Nat Genet 31:370-377
53. Zhu W, Giangrande PH, Nevins JR 2004 E2Fs link the control of G1/S and G2/M transcription. EMBO J 23:4615-4626
54. Wang W, Smith III R, Burghardt R, Safe SH 1997 17β-Estradiol- mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: cell cycle effects. Mol Cell Endocrinol 133:49-62
55. Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY 2003 E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 82:11-16
56. Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ 2000 E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 9:395-401
57. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS 1999 Estrogen receptor regulation of the Na+/H+ exchanger regulatory factor. Endocrinology 140:2976-2982
58. Frasor J, Danes JM, Funk CC, Katzenellenbogen BS 2005 Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proc Natl Acad Sci USA 102:13153-13157